Not all individuals with CLL call for therapy. Irrespective of all current improvements, the iwCLL however endorses watchful observation for patients with asymptomatic disease.86 This recommendation is based on at the least two randomized trials evaluating observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR). Long-term lymphocytic leukemia https://murrayv974tck2.ziblogs.com/profile